FindTrial
Sign In

Efficacy of long acting steroids intramuscular therapy in nephrotic syndrome: pilot study. - ND

Efficacy of long acting steroids intramuscular therapy in nephrotic syndrome: pilot study. - ND

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-007793-29-IT
Enrollment
Unknown
Registered
2008-03-21
Start date
2008-02-11
Completion date
Unknown
Last updated
2012-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NEPHROSIC SYNDROME MedDRA version: 9.1 Level: HLT Classification code 10018365 Term: Glomerulonephritis and nephrotic syndrome

Interventions

Trade Name: DEPOMEDROL Pharmaceutical Form: Solution for injection INN or Proposed INN: Methylprednisolone Concentration unit: mg/l milligram(s)/litre Concentration type: equal Concentration number: 4

Sponsors

ISTITUTO GIANNINA GASLINI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Steroid dependent or frequent relapser patients Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Steroid resistant patients or high risk for IM procedures

Design outcomes

Primary

MeasureTime frame
Main Objective: Remission of NS with only IM steroids;Secondary Objective: 1. reduction of steroid side effects;Primary end point(s): Remission of NS with only IM steroids—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026